Science Pharmacy Discovers a New Approach for Fungal Sinusitis Using Aerosolized Amphotericin B

Inhaled Amphotericin B may be the answer to eradicating Allergic Fungal Sinusitis. It has been proven that Amphotericin B kills fungus and it is currently being used in liquid form by the irrigation method (squirting it up your nose). Some patients find this practice cumbersome, painful and sometimes messy. Aerosolized Amphotericin B is an alternative that can be easily inhaled into the sinuses as easily as smoking a cigarette, but without the side effects of liquid irrigations. Aerosolized Amphotericin B can help prevent and control Allergic Fungal Sinusitis.

Camarillo, CA (PRWEB) August 21, 2007 -- Inhaled Amphotericin B may be the answer to eradicating Allergic Fungal Sinusitis. It has been proven that Amphotericin B kills fungus and is currently being used in liquid form by the irrigation method (squirting it up your nose). Some patients find this practice cumbersome, painful and sometimes messy. Aerosolized Amphotericin B is an alternative that can be easily inhaled into the sinuses as easily as smoking a cigarette, but without the side effects of liquid irrigations. Aerosolized Amphotericin B can help prevent and control Allergic Fungal Sinusitis.

This new aerosolized intranasal application, developed by Aerosol Science Laboratories Inc. (Camarillo, CA) is an alternative approach for successfully treating Allergic Fungal Sinusitis. The formulation is available in 5mg and 10mg doses with a dosing frequency of 2-3 times per day. Amphotericin B is known for being an unstable drug; however, ASL's formula is extremely stable in unit dose vials for 35 days at refrigerated temperatures. Each dose aerosolizes in only 3.5 minutes, which increases safety & patient compliance.

Unlike with the irrigation method, aerosolized Amphotericin B stays in the sinuses and does not flow out during treatment, improving patient compliance. For added safety and stability, each unit dose vial is sealed in a non-latex plastic vial and is protected from exposure to light.

Aerosol Science Laboratories has monitored patients on Amphotericin B for the past 16 months and has observed these findings: 1) Patients using aerosolized inhalant drugs easily accept and comply with their therapy. 2) Aerosolized drugs are easy to administer at a "mid-day" dose at work or school. Patients are often unlikely to irrigate at work or school due to embarrassment or peer pressure. 3) After symptoms subside, the dosing frequency can be reduced without loss of effectiveness.

The most important features of ASL's new aerosolized inhalant Amphotericin B formula are that 1) It is covered by most insurance drug plans and patient co-payments are relatively small. 2) Patient compliance is high due to the ease of use of the therapy. 3) Clinical studies have proven the effectiveness of Amphotericin B in eradicating fungus. 4) You do not have to be a sinus surgeon to prescribe this therapy. Any MD can prescribe aerosolized medications through ASL Pharmacy (http://www.aslrx.com).

For more detailed public press information please contact Cal Tarrant at 805-236-1679.

###